(Q43442484)

23 November 2017

title

Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors (English)

1 reference

23 November 2017

1 reference

Aden Ka-Yin Chan

1

1 reference

23 November 2017

Jesse Chung-Sean Pang

2

1 reference

23 November 2017

Nellie Yuk-Fei Chung

3

1 reference

23 November 2017

Kay Ka-Wai Li

4

1 reference

23 November 2017

Wai Sang Poon

5

1 reference

23 November 2017

Danny Tat-Ming Chan

6

1 reference

23 November 2017

Zhifeng Shi

7

1 reference

23 November 2017

Liang Chen

8

1 reference

23 November 2017

Liangfu Zhou

9

1 reference

23 November 2017

Ho-Keung Ng

10

1 reference

23 November 2017

language of work or name

1 reference

13 September 2013

1 reference

23 November 2017

1 reference

23 November 2017

volume

27

1 reference

23 November 2017

issue

3

1 reference

23 November 2017

page(s)

332-342

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2013.165

23 November 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Analysis of the IDH1 codon 132 mutation in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Identification of two contiguous minimally deleted regions on chromosome 1p36.31-p36.32 in oligodendroglial tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

A method and server for predicting damaging missense mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Capicua regulates cell proliferation downstream of the receptor tyrosine kinase/ras signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

A MAPK docking site is critical for downregulation of Capicua by Torso and EGFR RTK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

CIC, a member of a novel subfamily of the HMG-box superfamily, is transiently expressed in developing granule neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

FUSE-binding protein is developmentally regulated and is highly expressed in mouse and chicken embryonic brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Quantitative characterization of the interactions among c-myc transcriptional regulators FUSE, FBP, and FIR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Identification of genomic aberrations associated with shorter overall survival in patients with oligodendroglial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Oligodendrogliomas: new insights from the genetics and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.165

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/MODPATHOL.2013.165

1 reference

Dimensions Publication ID

23 November 2017

1012176186

0 references

1 reference